Cellid Co Ltd
KOSDAQ:299660
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cellid Co Ltd
KOSDAQ:299660
|
KR |
|
Charlotte's Web Holdings Inc
TSX:CWEB
|
US |
|
iExalt Inc
OTC:IEXA
|
US |
|
Rocky Mountain Ayre Inc
OTC:RMTN
|
US |
|
H
|
Hempalta Corp
XTSX:NPV
|
CA |
|
M
|
Minutor Energia SA
WSE:MTE
|
PL |
|
H
|
HNK Machine Tool Co Ltd
KOSDAQ:101680
|
KR |
|
M
|
Munic SA
F:MNS
|
FR |
|
X
|
Xinjiang Xinxin Mining Industry Co Ltd
F:33X1
|
CN |
|
Aptechnaya Set' 36,6 PAO
MOEX:APTK
|
RU |
|
H
|
Hanwha Plus No 3 Special Purpose Acquisition Co
KOSDAQ:430460
|
KR |
|
S
|
Security Bank Corp
XPHS:SECB
|
PH |
|
O
|
Oliver's Real Food Ltd
F:36S
|
AU |
|
C
|
Champ Resto Indonesia Tbk PT
IDX:ENAK
|
ID |
|
Oncologix Tech Inc
OTC:OCLG
|
US |
Bankruptcy Probability
Cellid Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cellid Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
C
|
Cellid Co Ltd
KOSDAQ:299660
|
63.7B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
469.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
184.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
140.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
63.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cellid Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cellid Co Ltd has total debt of 62.7m KRW. This includes both short-term (0 KRW) and long-term (62.7m KRW) debt.
You can find a full breakdown on its Balance Sheet.
